Skip to content

Research paper

Inhaled nitric oxide as adjunctive therapy for severe malaria: a randomized controlled trial

Malaria Journal
Q1
Oct 2015
Citations: 56
Influential: 2
Interventional (Human) Studies
90

Study answer

What this study found

BackgroundSevere malaria remains a major cause of childhood mortality globally. Decreased endothelial nitric oxide is associated with severe and fatal malaria. The hypothesis was that adjunctive inhaled nitric oxide (iNO) would improve outcomes in African children with severe malaria.MethodsA randomized, blinded, placebo-controlled trial of iNO at 80 ppm by non-rebreather mask versus room air placebo as adjunctive treatment to artesunate in children with severe malaria was conducted. The primary outcome was the longitudinal course of angiopoietin-2 (Ang-2), an endothelial biomarker of…

A separate results summary is not available, so this answer uses the paper abstract.

Study & population
Interventional (Human) Studies

Original abstract

BackgroundSevere malaria remains a major cause of childhood mortality globally. Decreased endothelial nitric oxide is associated with severe and fatal malaria. The hypothesis was that adjunctive inhaled nitric oxide (iNO) would improve outcomes in Af…